Gemmer Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-8
Closed -$1K – 382
2022
Q1
$1K Hold
8
– – ﹤0.01% 1186
2021
Q4
$1K Hold
8
– – ﹤0.01% 1213
2021
Q3
$1K Hold
8
– – ﹤0.01% 1232
2021
Q2
$1K Buy
+8
New +$768 ﹤0.01% 1464
2021
Q1
– Sell
-88
Closed -$8K – 1479
2020
Q4
$8K Sell
88
-32
-27% -$2.86K ﹤0.01% 767
2020
Q3
$12K Hold
120
– – ﹤0.01% 543
2020
Q2
$12K Buy
+120
New +$10.7K ﹤0.01% 524
2018
Q1
– Sell
-40
Closed -$1K – 1465
2017
Q4
$1K Hold
40
– – ﹤0.01% 1207
2017
Q3
$0 Hold
40
– – ﹤0.01% 1252
2017
Q2
$1K Hold
40
– – ﹤0.01% 1212
2017
Q1
$1K Buy
+40
New +$781 ﹤0.01% 1205

Other funds holding DXCM

Gemmer Asset Management's DXCM Position: Q2 2022 in Review

Gemmer Asset Management sold out of DexCom (DXCM) in Q2 2022, closing a stake of 8 shares — an estimated $1K sold.

Gemmer Asset Management first reported a position in DXCM in Q1 2017 and held it in 11 quarters. The position peaked at $12K in Q3 2020. 798 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Gemmer Asset Management reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Gemmer Asset Management sold 8 DexCom shares in Q2 2022, an estimated $1K.
  • Gemmer Asset Management first reported a position in DexCom in Q1 2017 and held it in 11 quarters.
  • Gemmer Asset Management's DexCom position peaked at $12K in Q3 2020.
  • 798 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.